Attention healthcare practitioners, did you know that the prevalence of allergic rhinitis and urticaria in children is 20 to 30 percent in India? That’s why we are introducing a novel anti-allergic combination that contains bilastin 10 mg and Montelukast 4 mg.
Bilastin is an H1 receptor antagonist, and Montelukast is a leukotriene receptor antagonist. The synergistic action of Bilastin and Montelukast helps in the management of allergic rhinitis and urticaria in children.
This combination has demonstrated established efficacy and safety in children aged 2 to 11 years with allergic rhinitis or chronic urticaria. Prolastin M offers four benefits over sedative antihistamines. It provides no daytime sleepiness, excellent symptom relief both in the day and night time, no effect on learning or concentration, and the child stays attentive in school.
Prolastin M has a delicious mango flavor, is lactose-free, and has a lower viscosity, which ensures complete dose delivery. It offers four-organ safety for the liver, kidney, heart, and brain, making it safe for children.
So, dear healthcare practitioners, we request you to prescribe Prolastin M suspension to your next patient suffering from allergic rhinitis and urticaria, available with a delicious mango flavor and a calibrated measuring cup. Let’s help children stay allergy-free and healthy.
Subscribe to our newsletters
We provide end-to end consultancy services to the pharmaceutical and healthcare sector to help increase the awareness of medicines.
9, Haribaug Building, Sitaram Jadhav Marg, Lower Parel (W), Mumbai – 400013.
+91 93236 68598
© 2018 – 2020
Spacedge Creation
Get regular update on our latest products and services